|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 71.9 TWD | -1.37% |
|
+1.27% | -4.89% |
| 15/05 | Polaris Group Voluntarily Withdraws the Phase III Clinical Trial Protocol for Liver Cancer from the FDA | CI |
| 14/05 | Polaris Group Announces Change of the Member of Compensation Committee | CI |
Polaris Group announced the appointment of Corporate Governance Officer. Name, title, and resume of the new position holder: Kay Huang, Chief Financial Officer of the company. Effective date is August 16, 2022.
| 1st Jan change | Capi. | |
|---|---|---|
| -4.89% | 1.67B | |
| +48.54% | 56.87B | |
| +37.15% | 39.72B | |
| -6.02% | 39.27B | |
| -6.90% | 28.73B | |
| +12.97% | 26.21B | |
| -16.91% | 19.79B | |
| +31.71% | 12.28B | |
| +28.18% | 12.23B | |
| +0.38% | 12.12B |
POLARIS GROUP 
